Fibrinolysis Comprehensive Panel

Fibrinolysis Comprehensive Panel

Test Code

90923
85360, 85362 (x2), 85379, 85410, 85415 (x2), 85420
90923
85360, 85362 (x2), 85379, 85410, 85415 (x2), 85420
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection is not available in your area through Quest Mobile.

Clinical Significance

Fibrinolysis Comprehensive Panel - An increase in PAI-1 antigen is associated with an increased risk for post-operative venous thrombosis, myocardial infarction, and (probably) stroke. A severe deficiency of alpha-2 antiplasmin or PAI-1 antigen has been associated with bleeding. A shortened euglobulin lysis time correlates with a severe deficiency of alpha-2 antiplasmin or PAI-1 antigen. Elevations in fibrin monomer, fibrinogen degradation products, and D-dimer usually indicate vascular thrombosis (mainly venous) but are also associated with malignancy and infection. Conversely, a normal D-dimer and/or negative fibrin monomer suggests ...

Test Resources

None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.

Test Details

Includes

  • Alpha-2-Antiplasmin
  • D-Dimer, Quantitative
  • Euglobulin Clot Lysis Time
  • Fibrinogen Degradation Products (FDP)
  • Plasminogen Activator Inhibitor (PAI-1) Ag
  • Plasminogen Activity
  • Tissue Plasminogen Activator (TPA), EIA
  • Fibrin Monomer

Patient Preparation

Morning fasting is required. Since lipemia may interfere with clotting endpoint detection, a two-hour fast is recommended.

Methodology

Chromogenic Assay • Clot Dissolution • Hemagglutination (HA) • Immunoassay (IA) • Latex Agglutination (LA)

Reference Range(s)

See Laboratory Report

LOINC® Codes, Performing Laboratory

Service Area must be determined
Alpha-2-Antiplasmin
D-Dimer, Quantitative
Euglobulin Clot Lysis Time
Fibrinogen Degradation Products (FDP)
Plasminogen Activator Inhibitor (PAI-1) Ag
Plasminogen Activity
Tissue Plasminogen Activator (TPA), EIA
Fibrin Monomer
Morning fasting is required. Since lipemia may interfere with clotting endpoint detection, a two-hour fast is recommended.

Methodology

Chromogenic Assay • Clot Dissolution • Hemagglutination (HA) • Immunoassay (IA) • Latex Agglutination (LA)

Reference Range(s)

See Laboratory Report
Service Area must be determined

Preferred Specimen(s)

1 mL frozen, platelet-poor plasma collected in each of five separate 3.2% sodium citrate (light blue-top) tubes

Minimum Volume

0.8 mL (x5)

Collection Instructions

Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and transport on dry ice.
To avoid release of plasminogen activator, do not massage vein vigorously, pump fist excessively or leave tourniquet in place for a prolonged period. Centrifuge within 30 minutes after collection to get platelet-poor plasma and freeze on dry ice. Prohibit exercise prior to drawing sample.

Transport Container

Transport tubes (x5)

Transport Temperature

Frozen

Specimen Stability

  • Room temperature: Unacceptable
  • Refrigerated: Unacceptable
  • Frozen: 14 days

Reject Criteria

Gross hemolysis • Grossly lipemic • Grossly icteric

Setup Schedule

Service Area must be determined
1 mL frozen, platelet-poor plasma collected in each of five separate 3.2% sodium citrate (light blue-top) tubes
0.8 mL (x5)
Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and transport on dry ice.
To avoid release of plasminogen activator, do not massage vein vigorously, pump fist excessively or leave tourniquet in place for a prolonged period. Centrifuge within 30 minutes after collection to get platelet-poor plasma and freeze on dry ice. Prohibit exercise prior to drawing sample.
Transport tubes (x5)
Frozen
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days

Gross hemolysis • Grossly lipemic • Grossly icteric

Service Area must be determined
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection is not available in your area through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.

Customize the test information for your Service Area
We'd love your feedback! Take a brief survey.